XTL Biopharmaceuticals Ltd. (XTLB)
NASDAQ: XTLB · Real-Time Price · USD
2.450
-0.030 (-1.21%)
Apr 17, 2026, 4:00 PM EDT - Market closed
XTL Biopharmaceuticals Market Cap
XTL Biopharmaceuticals has a market cap or net worth of $6.06 million as of April 17, 2026. Its market cap has decreased by -63.74% in one year.
Market Cap
6.06M
Enterprise Value
5.86M
1-Year Change
-63.74%
Ranking
Category
Stock Price
$2.45
Market Cap Chart
Since August 31, 2005, XTL Biopharmaceuticals's market cap has decreased from $179.98M to $6.06M, a decrease of -96.63%. That is a compound annual growth rate of -15.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2026 | 6.06M | -14.98% |
| Dec 31, 2025 | 7.12M | -68.18% |
| Dec 31, 2024 | 22.38M | 322.69% |
| Dec 31, 2023 | 5.30M | -16.54% |
| Dec 29, 2022 | 6.35M | -57.67% |
| Dec 30, 2021 | 14.99M | -4.38% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Addex Therapeutics | 6.58M |
| Akari Therapeutics, | 6.56M |
| PMGC Holdings | 6.35M |
| Aptevo Therapeutics | 6.24M |
| Purple Biotech | 6.17M |
| Ernexa Therapeutics | 6.06M |
| Cardio Diagnostics Holdings | 5.95M |
| Mustang Bio | 5.83M |